Biography

Ingrid Maes (°1966) holds a master’s degree of Engineering Sciences in Chemistry & Biotechnology (Brussels University). She also attended various post-university courses in management and business. Ingrid has 20 years’ experience in the pharma, biotech and life sciences industry and before joining PwC she had several positions at high-tech multinational technology and engineering companies, involved with strategy, innovation and new technology development, and managed worldwide innovative projects in the pharma and life sciences R&D and manufacturing area. Now she is Director at PwC Advisory and responsible for the pharma & life sciences sector for Belgium and business development for the EMEA region. Her key activity areas are: R&D and manufacturing, innovation & technology management, strategy and regulatory compliance. The last 8 years Ingrid has worked in the field of innovations, new technology evaluation, strategy and scenario planning for pharma and biotech companies. She is the author of many articles and presentations at international conferences and is involved in various pharma-related organisations, such as the executive committee of ASTM E55 (pharmaceutical manufacturing), MIT’s initiative on biopharma futures and the ISPE. She has presented inspectors and reviewers training at the FDA in Washington and advised the US government on anticipating the pandemic flu.

Her areas of expertise are:

• technical and operational due diligence

• market analysis, business plan development and strategic decision advice in the

pharmaceutical and biotech industry

• future visions and strategies for R&D and manufacturing, innovation & technology

management and regulatory compliance.

Abstract presentation

The new science of personalised medicine:

Translating the promise into practice